Categories

Unambiguous HLA typing: why full-length typing is a game-changer

HLA typing is a critical component in multiple areas of modern medicine: organ and bone marrow transplantation, clinical immunology, pharmacogenomics, and personalized medicine. However, for years, laboratories have faced a significant limitation: ambiguity in the results, especially when using short-read NGS-based methodologies.


Today, the arrival of full-length HLA typing solutions using nanopore sequencing marks a turning point. In this article, we explore why full-length HLA typing eliminates ambiguities, improves resolution, and becomes a real and efficient alternative for clinical and research laboratories.

The historical problem of HLA typing: ambiguity

HLA genes are characterized by being highly polymorphic and structurally complex. When analyzed using short read technologies , the result is usually:

  • Partial gene coverage
  • Difficulty in assigning complete haplotypes
  • Ambiguous results that require further interpretation
  • Longer analysis and validation time

In fact, in many NGS-based workflows, a single analysis can generate dozens or even hundreds of possible allelic combinations , which complicates clinical decision-making.

What does “full-length” really mean in HLA typing?

Full-length HLA typing involves amplification and sequencing of the entire gene , from beginning to end, in a single continuous read.

Thanks to nanopore technology:

  • A single reading covers the entire gene.
  • Direct information is obtained from the haplotype
  • The need for complex bioinformatics reconstructions is eliminated.
  • The resolution is truly high definition

This represents a conceptual change: possible combinations are no longer inferred, they are read directly .

Nanopore vs traditional NGS: key differences

1. Resolution and accuracy

While traditional NGS fragments genetic information, nanopore sequencing allows:

  • Uniform coverage of HLA genes
  • Precise discrimination between very similar alleles
  • Polished data with qualities close to Q30

2. Elimination of ambiguities

In comparative studies, full-length HLA typing has shown:

  • Total reduction of ambiguities compared to NGS
  • Up to 891 ambiguities eliminated in direct comparison
  • Clear and directly interpretable results

3. More reliable clinical information

The ability to identify complete haplotypes improves confidence in critical applications such as:

  • Donor-recipient compatibility
  • HLA-disease association studies
  • Personalized medicine and patient stratification

Full-length HLA: real impact in the laboratory

Adopting a full-length HLA typing solution not only improves the end result, but also optimizes the entire workflow:

  • Less time spent resolving ambiguities
  • Less dependence on additional analyses
  • Results ready in less than a day
  • Scalability from 1 to 96 samples per run

Furthermore, automating typing reduces inter-operator variability and increases the reproducibility of the analysis.

A new standard for HLA typing

The evidence is clear: full-length HLA typing using nanopore is not an incremental evolution , but a paradigm shift.

For laboratories seeking:

  • High resolution
  • Unambiguous results
  • Speed and operational efficiency
  • Clinical confidence

Full-length HLA is positioned as the new technological standard.


Artículos recomendados

See all
Filter tips
Filter tips
Filter tips for automatic pipettes with aerosol barrier. They protect against cross-contamination in PCR, molecular diagnostics, and cell biology. Universally compatible with major brands.
Oenological synergies: Winemaking with non-Saccharomyces and its control through precision analytics
Oenological synergies: Winemaking with non-Saccharomyces and its control through precision analytics
A comprehensive technical analysis of the application of non-Saccharomyces yeasts (Lachancea, Torulaspora, Metschnikowia) in winemaking and their direct analytical control. We detail the laboratory protocol (NFA, lactic acid, and viability) to ensure perfect sequential inoculation.
PhenoVue™ CNS: Analytical certainty in the identification of neurons and glial cells
PhenoVue™ CNS: Analytical certainty in the identification of neurons and glial cells
We analyzed Revvity's PhenoVue™ CNS, the all-in-one solution distributed by Proquinorte for the clear and reproducible characterization of hiPSC-derived neurons, astrocytes, and microglia
Discover your gift